News &amp; Updates

A blood-based biomarker (BBM) test for Alzheimer’s disease (AD) allows primary care physicians to diagnose AD with the same precision as specialists, suggests a study presented at AAIC 2026.

Blood test enables physicians to rule out Alzheimer’s disease in primary care

24 Jul 2026

Prolonged short sleep may lead to weight gain

Individuals who always have insufficient sleep tend to gain weight, according to a pooled analysis of randomized crossover trials (RCTs).

Prolonged short sleep may lead to weight gain

Parental nativity impacts LBW rates in SG

A study from Singapore identified an epidemiological paradox: Low birth weight (LBW; <2,500 g) rates were lower among socioeconomically disadvantaged foreign-born mothers than native-born mums.

Parental nativity impacts LBW rates in SG

Survodutide promotes weight loss in adults with obesity

In patients with obesity but without diabetes, treatment with survodutide results in substantial reductions in body weight compared with placebo, according to the phase III SYNCHRONIZE-1 trial.

Survodutide promotes weight loss in adults with obesity

Venglustat superior to ERT in Gaucher disease type 3

Treatment with oral venglustat demonstrates superior neurologic outcomes compared with standard enzyme replacement therapy (ERT) in patients with Gaucher disease type 3 (GD3), according to the phase III LEAP2MONO trial presented at EHA 2026.

Venglustat superior to ERT in Gaucher disease type 3

Real-world ES SCLC outcomes comparable between phase I trial participation and SoC

A single-centre retrospective observational study of 90 patients from Australia with extensive-stage small cell lung cancer (SCLC) shows that phase I clinical trial participation has acceptable safety and survival outcomes comparable to those of standard-of-care (SoC) treatment.

Real-world ES SCLC outcomes comparable between phase I trial participation and SoC

24 Jul 2026

Can blood type impact ICI efficacy in head and neck cancer?

A multi-omics study by researchers from Japan has found that blood type B (BTB) is associated with reduced immune checkpoint inhibitor (ICI) efficacy in first-line (1L) treatment of head and neck squamous cell carcinoma (HNSCC).

Can blood type impact ICI efficacy in head and neck cancer?

Patients with liver cirrhosis may sleep better with lemborexant

23 Jul 2026 by

Treatment with lemborexant helps manage sleep disturbances in patients with liver cirrhosis, as shown in the crossover RESTORE trial.

Patients with liver cirrhosis may sleep better with lemborexant

GLP-1RAs up risk for ischaemic optic neuropathy in T2D patients

The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) results in an increased risk for ischaemic optic neuropathy (ION) at 18 months when compared with the use of sodium‒glucose cotransporter-2 inhibitors (SGLT2is) and dipeptidyl peptidase-4 inhibitors (DPP4is), reports a study.

GLP-1RAs up risk for ischaemic optic neuropathy in T2D patients

Timing of surgery, physiotherapy predict 24-h discharge after TKA

23 Jul 2026 by

Patients who underwent total knee arthroplasty (TKA) in the morning and received physiotherapy review in the same afternoon have a higher chance of being discharged within 24 h, suggests a Singapore study. This is possible because of early ambulation and adequate time for the spinal anaesthesia to wear off.

Timing of surgery, physiotherapy predict 24-h discharge after TKA